Highlights Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Market Closed - Nyse Other stock markets 04:00:02 2024-04-30 pm EDT			5-day change	1st Jan Change
43.94 ^USD	-1.57%		-10.31%	-14.36%

05:18pm	Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla...
03:27pm	A flurry of corporate results ahead of the Fed's rate decision

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla...	11:18am
A flurry of corporate results ahead of the Fed's rate decision	09:27am
Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb	05:00am	CI
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion	03:41am	RE
J&J, Bristol Myers lose challenges to US drug price negotiation program	Apr. 29	RE
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases	Apr. 29	CI
S&P 500 Q1 earnings estimated growth improves; stocks up for week	Apr. 26	RE
Bristol-Myers Squibb Says European Regulator Recommends Approval of Bladder Cancer Combination Therapy	Apr. 26	MT
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma	Apr. 26	CI
Health Care Drops Amid Mixed Earnings -- Health Care Roundup	Apr. 25	DJ
Sector Update: Health Care Stocks Decline Late Afternoon	Apr. 25	MT
Sector Update: Health Care Stocks Drop in Afternoon Trading	Apr. 25	MT
Sector Update: Health Care	Apr. 25	MT
Bristol-Myers Squibb Swings to Q1 Non-GAAP Loss, Revenue Rises; Provides 2024 Guidance -- Shares Fall	Apr. 25	MT
Tranche Update on Bristol-Myers Squibb Company's Equity Buyback Plan announced on October 27, 2016.	Apr. 25	CI
Global markets live: Ford, Dow, American Airlines, Comcast, Apple, IBM, Cisco...	Apr. 25
Stocks in motion: Large caps struggle	Apr. 25
Trending : Bristol Myers Squibb Cuts '24 EPS Outlook, Plans Job Cuts in Cost Saving Efforts	Apr. 25	DJ
The specter of stagflation rears its ugly head again	Apr. 25
Bristol-Myers Squibb Swings to Q1 Non-GAAP Loss, Revenue Rises; Provides 2024 Guidance	Apr. 25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

January 09, 2024 at 01:06 pm EST